148 related articles for article (PubMed ID: 11490761)
1. [Long-term outcome of stomach carcinoma achieved in an Austrian standard hospital with an oncologic focus].
Jagoditsch M; Pertl A; Jatzko GR; Denk H; Stettner HM
Chirurg; 2001 Jul; 72(7):822-31. PubMed ID: 11490761
[TBL] [Abstract][Full Text] [Related]
2. [Stomach carcinoma. Optimizing therapy by extended lymph node dissection].
Jatzko GR; Lisborg PH; Denk H; Stettner HM
Zentralbl Chir; 1999; 124(5):376-80. PubMed ID: 10420521
[TBL] [Abstract][Full Text] [Related]
3. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.
Jatzko GR; Lisborg PH; Denk H; Klimpfinger M; Stettner HM
Cancer; 1995 Oct; 76(8):1302-12. PubMed ID: 8620402
[TBL] [Abstract][Full Text] [Related]
4. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
5. [Gastrectomy with radical lymphadenectomy--standard therapy of adenocarcinoma of the stomach].
Thybusch A; Schmid A; Henne-Bruns D; Kremer B
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():173-5. PubMed ID: 9101822
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
7. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
8. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
9. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
10. The radical treatment of gastric carcinoma.
Ranzato R; Fiamingo P; Veroux M; D'Amico DF
Minerva Chir; 2004 Oct; 59(5):471-7. PubMed ID: 15494674
[TBL] [Abstract][Full Text] [Related]
11. Rationale for gastrectomy with D2 lymphadenectomy in the treatment of gastric cancer.
Díaz de Liaño A; Yarnoz C; Aguilar R; Artieda C; Ortiz H
Gastric Cancer; 2008; 11(2):96-102. PubMed ID: 18595016
[TBL] [Abstract][Full Text] [Related]
12. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
14. Total gastrectomy for gastric cancer: an analysis of postoperative and long-term outcomes through time: results of 413 consecutive cases in a single cancer center.
da Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; de Farias IC; Begnami MD; Soares FA
Ann Surg Oncol; 2015 Mar; 22(3):750-7. PubMed ID: 25366586
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of gastric tumours in our practice: a five year survey].
Ondrejka P; Bereczky B; Ráth Z; István G; Forgács B; Sugár I
Zentralbl Chir; 2004 Apr; 129(2):122-4. PubMed ID: 15106044
[TBL] [Abstract][Full Text] [Related]
16. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
[TBL] [Abstract][Full Text] [Related]
17. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
[TBL] [Abstract][Full Text] [Related]
18. The Turkish experience with curative gastrectomies for gastric carcinoma: is D2 dissection worthwhile?
Yildirim E; Celen O; Berberoglu U
J Am Coll Surg; 2001 Jan; 192(1):25-37. PubMed ID: 11192920
[TBL] [Abstract][Full Text] [Related]
19. [Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].
Schafmayer C; Jürgens G; Jürgens I; Klomp HJ; Fändrich F; Kahlke V
Zentralbl Chir; 2007 Dec; 132(6):515-22. PubMed ID: 18098079
[TBL] [Abstract][Full Text] [Related]
20. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
